FDA Clears Ultrasound AI Module for Detection of Fetal Anomalies
Recent multicenter research showed a 22 percent improvement in the detection of fetal anomalies with the Sonio Suspect AI-powered ultrasound module.
The Food and Drug Administration (FDA) has granted 510(k) clearance for Sonio Suspect, an artificial intelligence (AI)-enabled module that reportedly facilitates enhanced ultrasound detection of fetal anomalies.
Approximately 51 percent of fetal anomalies are not detected during conventional prenatal ultrasound screenings, according to Sonio, the developer of the Sonio Suspect software. The company says Sonio Suspect provides automated detection of eight ultrasound findings of fetal abnormalities across the heart, brain, and abdomen.
In a recent 47-facility multicenter study, Sonio said the Sonio Suspect module achieved a 91 percent area under the receiver operating characteristic curve (AUC) for fetal anomaly detection. (Image courtesy of Sonio.)
In a recent 47-facility multicenter study, Sonio said the Sonio Suspect module achieved a 91 percent area under the receiver operating characteristic curve (AUC) for fetal anomaly detection, a 22 percent improvement over unassisted interpretation. The company said the improved detection with Sonio Suspect was consistent regardless of clinician experience or background.
“By combining real-time AI quality control with AI-driven anomaly detection, Sonio supports ultrasound providers from exhaustive documentation to accurate diagnosis,” noted Cecile Brosset, the CEO and co-founder at Sonio. “Our technology is designed to help health-care providers detect issues early and streamline processes, ultimately improving the care every patient receives.”
Study Assesses Potential of Seven-Minute AI-Enhanced 3T MRI of the Shoulder
February 20th 2025Researchers found that the use of seven-minute threefold parallel imaging-accelerated deep learning 3T MRI had 89 percent sensitivity for supraspinatus-infraspinatus tendon tears and 93 percent sensitivity for superior labral tears.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
